Juniper Pharma (JNP) Tops Q1 EPS by 11c

Juniper Pharma (NASDAQ: JNP) reported Q1 EPS of $0.03, $0.11 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $12.1 million versus the consensus estimate of $9.13 million.

For earnings history and earnings-related data on Juniper Pharma (JNP) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Stantec (STN) Tops Q2 EPS by 47c
• Aptera Motors (SEV) Reports Q2 Loss of $0.20